Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00391820 · ClinicalTrials.gov registry record · Phase 2
Evaluate the Safety and Efficacy of a 5-HT4 Agonist in Chronic Constipation (ACCORD Trial)
A Phase 2 study, sponsored by Alfasigma S.p.A..
- Completed
- Registry status
- Phase 2
- Development phase
- 360
- Enrollment target
NCT00391820: Completed Phase 2 study, sponsored by Alfasigma S.p.A..
NCT00391820 is a Phase 2 study that has completed, run by Alfasigma S.p.A.. The registered enrollment target is 360 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (171% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00391820, a Phase 2 study, has completed, sponsored by Alfasigma S.p.A..
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 360 participants
- Enrollment target
Study Summary
Study 0038 compares the safety and effectiveness of an investigational drug, TD-5108 with placebo (a sugar pill) for the treatment of chronic constipation.
Interventions
- DRUG TD-5108
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 360 participants |
| Start Date | 2006-10 |
| Est. Completion | 2007-05 |
| Phase | Phase 2 |
What the finished NCT00391820 record still lists
NCT00391820 is an interventional study that assigns participants to a tested intervention. The registered 360 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (171% higher).
The record links to 0 conditions, and to 1 intervention - of which TD-5108 is the first listed.
NCT00391820 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00391820 about?
NCT00391820 is a clinical study titled "Evaluate the Safety and Efficacy of a 5-HT4 Agonist in Chronic Constipation (ACCORD Trial)". Study 0038 compares the safety and effectiveness of an investigational drug, TD-5108 with placebo (a sugar pill) for the treatment of chronic constipation.
What is the current status of trial NCT00391820?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 360 participants. The study started on 2006-10. Estimated completion is 2007-05.
What interventions are being tested in trial NCT00391820?
The interventions under investigation include: TD-5108 (DRUG).
Who is sponsoring clinical trial NCT00391820?
This trial is sponsored by Alfasigma S.p.A., which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00391820's enrollment target sits among peer trials
360 123rd of 2000 higher than 1,874 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747836 · 360 participants
Ultrasound Analysis of Human Carpal Tunnel System
- NCT04089046 · 360 participants · NA
Telemedicine Enhanced Asthma Management - Uniting Providers for Teens (TEAM-UP for Teens)
- NCT04130503 · 360 participants · NA
The Recovery in Stroke Using PAP Study
- NCT04160000 · 360 participants · Phase 4
Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia